Clinical Trial Update: Anakinra in the Management of COVID-19 Infection [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating anakinra for COVID-19–related pneumonia and cytokine release syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Covid19, Pneumonia | Phase 2, Phase 3 | Status: COMPLETED